Search This Blog

Monday, November 4, 2019

Genomic Health reported EPS beat of $0.10

Genomic Health (NASDAQ:GHDX): Q3 GAAP EPS of $0.48 beats by $0.10.
Revenue of $114.36M (+12.9% Y/Y) beats by $2.09M.
Reported on Oct. 30, 2019.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)